Foxo Technologies Inc. last reported quarterly results on Aug 10, 2023, for the quarter ended Jun 30, 2023. It usually reports 41 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 41 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 10, 2023
41 days after quarter end
|
—
ended Jun 30, 2023
|
—
|
—
|
—
|
|
May 11, 2023
41 days after quarter end
|
—
ended Mar 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- FOXO (OTC), FOXOW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Palm Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1812360
- Former names
- Delwinds Insurance Acquisition Corp. (until Sep 15, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.